1The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group.Tissue plasminogen activator for acute ischemic stroke[J].N Engl J Med,1995,333(24):1581-1587.
2California Acute Stroke Pilot Registry(CASPR) Investigations.Prioritizing interventions to improve rates of thrombolysis for ischemic stroke[J].Neurology,2005,64(4):654-659.
3Cocho D,Belvis R,Marti-Fabregas J,et al.Reasons for exclusion from thrombolytic therapy following acute ischemic stroke[J].Neurology,2005,64(4):719-720.
1[1]Grotta J C, Welch KMA, Fagan S C, et al. Clinical deterioration following improvement in the NINDS rt - PA stroke trial.Stroke, 2001,52:661～668.
2[2]Larrue V, Kummer R, Muller A, et al. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator. Stroke, 2001,32:438～441.
1Kim AS, Johnston SC. Global variation in the relative burden of stroke and ischemic heart disease [ J]. Circulation, 2011, 124 (3) : 314 - 323.
2Hacke W, Kaste M, Bluhraki E, et al. Thrombolysis with aheplase 3 to 4.5 hours after acute ischemic stroke [J ]. N Engl J Med, 2008, 359 (13): 1317-1329.
3WHO MONICA Project Principal Investigators. The World Health Organization MONICA Project ( monitoring trends and determinants in cardiovascular disease) : a major international collaboration [ J ]. J Clin Epidemiol, 1988, 41 (1988) : 105 - 114.
4Kleindorfer D, Lindsell C J, Mcmaw C J, et al. Which stroke symptoms prompt a 911 call? A.population -based study [J]. Am J Emerg Med, 2010, 28 (5): 607-612.
5Curran C, Henry C, O'Connor KA, et al. Predictors of early arrival at the emergency department in acute ischaemic stroke [ J ]. Ir J Med Sci, 2011, 180 (2): 401-405.
6Lees KR, Bluhmki E, Kummer RV, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled anal,sis of ECASS, ATLANTIS, NiNDS, and EPITHET trims [J]. Lancet, 2010, 375 (9727): 1695-1703.
7Fonarow GC, Smith EE, Saver JL, et al. Timeliness of tissue - type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door - to- needle times within 60 minutes [ J]. Circu|ation, 2011, 23 (7) : 750 -758.
